Drugs / Recombinant choriogonadotropin alfa
Recombinant choriogonadotropin alfa
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02118051 Background | Sep 2013 → Jun 2017 | infertility disorder | La Fe Health Research Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant choriogonadotropin alfa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02118051 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant choriogonadotropin alfa.” NCT02118051 ↗ |